Back to Search Start Over

Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study

Authors :
Brigitte F. M. Slangen
J. van der Velden
A.G.J. van der Zee
R.G.V. Smolders
F. Hinten
Anne-Floor W. Pouwer
Henriette J. G. Arts
D. Boll
Joanna IntHout
Henry Zijlmans
Katja N. Gaarenstroom
J.A. de Hullu
Obstetrics & Gynecology
Cancer Center Amsterdam
Obstetrics and Gynaecology
CCA - Cancer Treatment and Quality of Life
RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Promovendi ODB
Dermatologie
Obstetrie & Gynaecologie
RS: GROW - R2 - Basic and Translational Cancer Biology
MUMC+: MA Medische Staf Obstetrie Gynaecologie (9)
Targeted Gynaecologic Oncology (TARGON)
Source :
Gynecologic Oncology, 146, 3, pp. 580-587, Gynecologic Oncology, 146(3), 580-587. Academic Press, Gynecologic oncology, 146(3), 580-587. Academic Press Inc., Gynecologic Oncology, 146(3), 580-587. Elsevier Science, Gynecologic Oncology, 146(3), 580-587. ACADEMIC PRESS INC ELSEVIER SCIENCE, Gynecologic Oncology, 146, 580-587, Gynecologic Oncology, 146(3), 580-587
Publication Year :
2017

Abstract

Item does not contain fulltext OBJECTIVE: Inguinofemoral lymphadenectomy for patients with vulvar squamous cell carcinoma is associated with a high incidence of postoperative wound complications, which may be influenced by inguinal drain management. The aim of this nationwide prospective study (MAMBO: Morbidity And Measurement of the BOdy) was to assess the feasibility and the incidence of complications after volume-controlled versus short drainage. METHODS: The MAMBO study consisted of two observational studies in all eight oncology centers in the Netherlands, conducted between 2012 and 2016. In the first study, the drain was removed when the production was

Details

ISSN :
00908258
Database :
OpenAIRE
Journal :
Gynecologic Oncology, 146, 3, pp. 580-587, Gynecologic Oncology, 146(3), 580-587. Academic Press, Gynecologic oncology, 146(3), 580-587. Academic Press Inc., Gynecologic Oncology, 146(3), 580-587. Elsevier Science, Gynecologic Oncology, 146(3), 580-587. ACADEMIC PRESS INC ELSEVIER SCIENCE, Gynecologic Oncology, 146, 580-587, Gynecologic Oncology, 146(3), 580-587
Accession number :
edsair.doi.dedup.....9bb3b39dbfa279b6db3978b342212d1e